Thus, we assessed each POLE variant in Group 3 tumors, according to the cancer type and overall, considering the 3-nucleotide context associated with COSMIC mutational signatures SBS 10a, 10b, 14, and 28 [Fig. 2C–2E; Supplementary Fig. S2A (overall)]. Here, POLE is linked to cancer.